Navigation Links
ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008
Date:9/4/2008

ADDISON, Texas, Sept. 4 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it is scheduled to present at the Thomas Weisel Partners Healthcare Conference at 3:15 p.m. Eastern Time on Thursday, September 4, 2008.

About ULURU Inc.:

ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the response to the product from physicians and nurses, the importance of use of the product for burn victims, our expectation of enhanced patient comfort, the ability to use the product for chronic wounds, the perception of the product as a transformational innovation in the wound care market, our plan to add two products to our wound care franchise in 2009, and our expectation of filing a 510k in the third quarter and a product launch in the first quarter of 2009. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company

Kerry P. Gray

President & CEO

Terry K. Wallberg

Vice President & CFO

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
2. ULURU Inc. Reports First Quarter 2008 Financial Results
3. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
4. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
5. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
8. ULURU Inc. Reports Third Quarter 2007 Results
9. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
10. ULURU Inc. Announces Odd-Lot Buy Back Offer
11. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)..., Dec. 2 To support medication-sa...um (UHC) and Safecor Health, LLC, announced today ...ment for bar-coded pharmaceutical repackaging serv..., , "UHC is very pleased with the addition ...f agreements and is excited to embark on a partner...
(Date:12/2/2008)...Prevention, Shedding, or Sharing Costs as Key , ...-- A New Center for State and Local Government Exc...etiree health care plans and their need to contain...rican States examines how state administrators pe...its to central human resources (HR) goals; how the...
(Date:12/2/2008)...o 70 Cities and Regions by 2010 , , PRINCET... first investment of a new $44 million initiative,...rded grants of up to $400,000 to nine communities ...s for its most ambitious effort yet to reverse the...ids, Healthy Communities will support local actio...
(Date:12/2/2008)... aprotinin, a drug commonly used to control blood ...ared with lysine analogues, according to a study ...e published in the January 20th issue of CMAJ . ... panel will meet to decide on aprotinin use. The s...ting. , The study, a systematic review of 49 ra...
Breaking Medicine News(10 mins):Health News:UHC and Safecor Health Announce Multi-Year Agreement for Repackaging Bar-Coded Medications 2Health News:States View Limits on Retiree Health Benefits 2Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 2Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 3Health News:Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity 4
...o scientists Vivian Cheung and Warren Ewens from t...isorders that are recessively inherited. Gene exp...ould differ significantly and this new diagnostic ...echnology to identify differences in genome-wide e...
...ing cattle with many growth hormones that are extr... among EU nations that import beef, necessitating ...expert and a pharmaceutical chemist, John Verrall ...ts of consuming beef from cattle that have been in...
...ers, a woman who lost her husband to AIDS and is n...in her Bihar home. Premila Devi, 40, from Tilaei ...ing into a well Saturday, just a few months after ...d of AIDS. "She was upset by the way her family m...
... babies’ to be overweight, which is thought to be ...’ diet during pregnancy. A study that analyzed nea... UK, the Scottish babies’ weight scored the highes...tuation can be remedied if pregnant women were mad...
Other Medicine News:Health News:New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders 2
(Date:12/1/2008)...NB-0040 at Children,s Hospital, Health Sciences Ce...wswire/ -- Enobia Pharma, an emerging Canadian bio...ics for serious bone disorders, today announced th...m for hypophosphatasia was dosed. Enobia is invest...0040 for the treatment of this rare and often crip...
(Date:12/1/2008)...-FirstCall/ -- Following a,Request for Proposal i...sed,third generation smallpox vaccine, Public Wo...the Canadian Department of National Defence, has a...very of IMVAMUNE(R). , The Canadian authori...ntry,s bio-preparedness programme. , The co...
(Date:11/30/2008)...wire/ -- Older adults who exercise regularly show ... of small blood vessels in the brain, according to... the Radiological Society of North America (RSNA)....ty of North Carolina ( UNC) - Chapel Hill , is th... exercise to brain scans of those who do not. , ...
(Date:11/27/2008)...astic leukemia relapse cases arise from a cell alr...EMPHIS, Tenn., Nov. 27 ...l have identified distinctive genetic changes in t...ic leukemia (ALL) that cause relapse. The finding ...elapse in children and, ultimately, in adults. , ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts 29545 1Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts 29545 2Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts 29545 3Drug Resistant TB Declines in United States 29543 1Drug Resistant TB Declines in United States 29543 2Study 3A Smoking Ban Would Help Reduce Heart Attack Admissions 29538 1Study 3A Smoking Ban Would Help Reduce Heart Attack Admissions 29538 2Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 29534 1Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 29534 2Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 29534 3Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 29534 4Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 29534 5
... WIRE)--Jul 11, 2007 - The Journal of the,American...rly,results of a clinical study conducted by Dr. S...hat the topical gel, Regenecare(R),caused a stati...hing of a rash that results from the use of anti-c... supportive care trial is,listed on the National C...
...tributing Editor , ,Celiac disease (CD) is an...stine that is triggered in genetically susceptible... grains wheat, rye, barley, and possibly oats. The...n of both a T-cell and B-cell immune response, lea... crypt hyperplasia, and is self-perpetuating with ...
Other Medicine Technology:Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3
For determination of HDL-cholesterol in serum and plasma. For Hitachi 717. Specific immunochemical inhibition of non-HDL-lipoproteins. Excellent correlation with established reference methods. Endpoi
Cholesterol/HDL Standard 50 mg/dl.
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included.
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Medicine Products: